CharlesDavisAllenIIIMDPharmD

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
70 Peachtree Rd
Asheville, NC 28803
Phone+1 828-277-6789

Fax+1 828-277-6780

Dr. Davis Allen is an Internist in Asheville, NC. He received his medical degree from Brody School of Medicine at East Carolina University and did his residency at Duke University. He has been in practice 15 years. He specializes in Internal Medicine, and is experienced in the prevention of the four horseman (cardiovascular disease, cancer, neurodegenerative diseases, and metabolic dysfunction).

Duke University HospitalResidency, Internal Medicine, 2006 - 2009
Brody School of Medicine-East Carolina UniversityDoctor of Medicine, 2002 - 2006
Brody School of Medicine at East Carolina UniversityClass of 2006
University of North CarolinaDoctorate of Pharmacy, 1998 - 2002
University of North CarolinaBS, Biology, Graduated with Distinction, 1993 - 1997

Abstracts/Posters

To monitor or not? The Findings of an Outpatient Anticoagulation Service for Target-Specific Oral Anticoagulants.
Luck K, Duffey K, Allen D, et al, The Anticoagulation Forum, Phoenix, AZ, 5/9/2013
Does the potential for treatment with targeted agents influence prognostic communication in Oncology?
Allen D, Tulsky J, and Abernethy A., Duke University Medical Center Grand Rounds, Durham, NC, 6/22/2007
Both farnesylpyrphosphate (FFP) and geranylgeranylpyrophosphate (GGPP) rescue prenylation in the presence of Ras, but only GGPP rescues cell viability.
Burke, L and Allen D., American Association for Cancer Research, Orlando, Florida, 3/27/2004
Geranylgeranylation rescues Acute Promyelocytic Leukemia cells from statin-induced cytotoxicity.
Allen D, AMSA 54th Annual Conference, Kansas City, MO, 3/19/2004
Join now to see all

Physician Advisor, Anticoagulation Safety Program for Mission Hospital 2016 - Present
Physician Member, PE Response Team 2016 - Present
Physician Advisor, Warfarin Inpatient Management Team/Mission Health Inpatient Anticoagulation 2011 - Present
Member, Anticoagulation Subcommittee of P&T 2011 - Present
Member, Protocols & Procedures and CDC subcommittee of P&T committee 2010 - Present

Site InvestigatorComparison of Oral Anticoagulants for Extended Venous Thromboembolism (COVET) Trial; DCRI2018 - Present
Site Investigator for Mission Health SystemThe BRIDGE (Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery) Trial; sponsored by Duke Clinical Research Institute and National Institutes of Health2011 - 2014